A growth study of Coxiella burnetii Nine Mile Phase I and Phase II in fibroblasts - PubMed (original) (raw)
A growth study of Coxiella burnetii Nine Mile Phase I and Phase II in fibroblasts
J D Miller et al. FEMS Immunol Med Microbiol. 2004.
Free article
Abstract
Coxiella burnetii, a slow-growing, gram-negative, obligate intracellular bacterium, is the causative agent of Q fever in humans. The avirulent Phase II C. burnetii Nine Mile strain can invade and establish persistent infections in a wide variety of laboratory cell lines, and is generally considered to be easier to grow in culture than the wild-type Phase I organism. Efforts to improve Phase I organism yield in the BHK-21 cell line demonstrated that high CO2 conditions and the use of Dulbecco's modified Eagle's medium (DMEM) with 4.5 g/l glucose supplementation resulted in higher organism yields. Phase II organisms grown in the same cell line and conditions showed lower growth rates. Analysis revealed that increased average numbers of C. burnetii Phase I organisms within fibroblasts was due to higher growth rates within the hosts rather than to increased uptake or to increased cell-to-cell spreading. Addition of the nucleoside cytidine to the growth medium stimulated growth of Phase II but not Phase I organisms.
Similar articles
- Virulence of pathogenic Coxiella burnetii strains after growth in the absence of host cells.
Kersh GJ, Oliver LD, Self JS, Fitzpatrick KA, Massung RF. Kersh GJ, et al. Vector Borne Zoonotic Dis. 2011 Nov;11(11):1433-8. doi: 10.1089/vbz.2011.0670. Epub 2011 Aug 25. Vector Borne Zoonotic Dis. 2011. PMID: 21867419 - Coxiella burnetii infection.
Kazar J. Kazar J. Ann N Y Acad Sci. 2005 Dec;1063:105-14. doi: 10.1196/annals.1355.018. Ann N Y Acad Sci. 2005. PMID: 16481501 Review. - Analysis of whole cell lysate from the intercellular bacterium Coxiella burnetii using two gel-based protein separation techniques.
Samoilis G, Psaroulaki A, Vougas K, Tselentis Y, Tsiotis G. Samoilis G, et al. J Proteome Res. 2007 Aug;6(8):3032-41. doi: 10.1021/pr070077n. Epub 2007 Jun 29. J Proteome Res. 2007. PMID: 17602512 - Highly sensitive real-time PCR for specific detection and quantification of Coxiella burnetii.
Klee SR, Tyczka J, Ellerbrok H, Franz T, Linke S, Baljer G, Appel B. Klee SR, et al. BMC Microbiol. 2006 Jan 19;6:2. doi: 10.1186/1471-2180-6-2. BMC Microbiol. 2006. PMID: 16423303 Free PMC article. - Intracellular life of Coxiella burnetii in macrophages.
Ghigo E, Pretat L, Desnues B, Capo C, Raoult D, Mege JL. Ghigo E, et al. Ann N Y Acad Sci. 2009 May;1166:55-66. doi: 10.1111/j.1749-6632.2009.04515.x. Ann N Y Acad Sci. 2009. PMID: 19538264 Review.
Cited by
- The attenuated nine mile phase II clone 4/RSA439 strain of Coxiella burnetii is highly virulent for severe combined immunodeficient (SCID) mice.
Islam A, Lockhart M, Stenos J, Graves S. Islam A, et al. Am J Trop Med Hyg. 2013 Oct;89(4):800-3. doi: 10.4269/ajtmh.12-0653. Epub 2013 Aug 19. Am J Trop Med Hyg. 2013. PMID: 23958905 Free PMC article. - A method for purifying obligate intracellular Coxiella burnetii that employs digitonin lysis of host cells.
Cockrell DC, Beare PA, Fischer ER, Howe D, Heinzen RA. Cockrell DC, et al. J Microbiol Methods. 2008 Mar;72(3):321-5. doi: 10.1016/j.mimet.2007.12.015. Epub 2008 Jan 12. J Microbiol Methods. 2008. PMID: 18242746 Free PMC article. - Characterization of Early Stages of Human Alveolar Infection by the Q Fever Agent Coxiella burnetii.
Dragan AL, Kurten RC, Voth DE. Dragan AL, et al. Infect Immun. 2019 Apr 23;87(5):e00028-19. doi: 10.1128/IAI.00028-19. Print 2019 Mar. Infect Immun. 2019. PMID: 30833339 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources